Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

IXICO (LSE:IXI): AIM Stock in Focus as New Huntington Disease Research Presentation Reshapes Investor Questions

IXICO (LSE:IXI) drew attention following its 29 October 2026 announcement concerning new Huntington disease research presentation.

Ankur Sharma | 30 October 2026

IXICO Plc (LSE:IXI): Why This AIM Stock Is Drawing Investor Attention on 30 October 2026

IXICO Plc (LSE:IXI) is being assessed against neuroimaging clinical trial contracts, study timing and pipeline.

Ankur Sharma | 30 October 2026

Allergy Therapeutics plc (LSE:AGY): Why This AIM market Stock Is in Focus on 30 October 2026 and What Comes Next

Allergy Therapeutics plc (LSE:AGY) is attracting attention around questions about clinical or commercial progress and funding visibility, while investors assess the implications for future business performance.

Ankur Sharma | 30 October 2026

FTSE 100 Spotlight: Why AstraZeneca PLC (LSE:AZN) Is Drawing Investor Attention on 30 October 2026

• The company operates through oncology and specialist treatments, with execution quality central to its investment case.

Ankur Sharma | 30 October 2026

FTSE 100 Watch: Can Smith & Nephew plc (LSE:SN.) Turn Sector Momentum Into Its Next Market Catalyst?

The most useful operating signals include product launches, procedure volumes, sales mix, innovation and operating margins.

Ankur Sharma | 30 October 2026

FTSE 100: Smith & Nephew plc (LSE:SN.) in Focus as Investors Weigh Medical-device demand

Smith & Nephew plc (LSE:SN.) is drawing investor attention around medical-device demand and operating-margin recovery.

Ankur Sharma | 30 October 2026

FTSE 100: GSK plc (LSE:GSK) in Focus as Investors Weigh Its third-quarter earnings

GSK plc (LSE:GSK) is drawing investor attention around its third-quarter earnings and investors' reassessment of the outlook.

Ankur Sharma | 30 October 2026

FTSE 100: Haleon PLC (LSE:HLN) in Focus as Investors Weigh Its reduced organic sales-growth outlook

Haleon PLC (LSE:HLN) is drawing investor attention around its reduced organic sales-growth outlook and sharp share-price reaction.

Ankur Sharma | 30 October 2026

Coloplast (LSE:0QBO) opens EUR 100 million Portugal factory, its largest manufacturing site

Coloplast A/S said on 29 October 2026 that it has opened a new factory in Felgueiras, Portugal, to support its global growth. The inauguration took place the same day and was attended by national and local authorities, Coloplast leadership and employees. Production at the …

Ankur Sharma | 30 October 2026

Haleon (LSE:HLN) Q3 organic revenue growth of 2.6% falls short of its own expectations; £500m buyback begins

Haleon plc published its trading statement for the three months to 30 September 2026 on 29 October, together with a separate notice confirming that a share buyback programme of up to £500 million had commenced.

Ankur Sharma | 30 October 2026
Support

Hi! How can we help you today?

Loading…